Overactive Bladder & Urge Incontinence in Women: An India Guide

• Overactive bladder means sudden urinary urgency, usually with frequent peeing (more than 8 times a day) and waking at night to pee, with or without leaks.
• It is highly treatable. Most women improve a lot with simple steps: managing fluids, cutting bladder irritants like caffeine, treating constipation, and bladder retraining.
• Pelvic floor exercises plus medicines (anticholinergics such as solifenacin, or the beta-3 agonist mirabegron) help when lifestyle changes alone are not enough.
• After menopause, low-dose vaginal oestrogen often eases urgency, frequency and recurrent infections, and is very under-used in India.
• Refractory cases respond well to bladder Botox or sacral neuromodulation. See a urogynaecologist or urologist if first-line measures do not work.
• Drinking less water to avoid leaks usually backfires, concentrated urine irritates the bladder and worsens urgency.

Overactive bladder is a syndrome, defined by the International Continence Society as urinary urgency, a sudden, compelling need to pee that is hard to put off, usually with frequency (peeing more than 8 times in 24 hours) and nocturia (waking at night to pee), with or without urge incontinence. The underlying problem is that the bladder muscle (the detrusor) contracts involuntarily while the bladder is still filling. A healthy bladder fills quietly to around 300-500 ml, and the first urge appears at about 200-300 ml. In OAB it starts squeezing at much lower volumes, which is why the urge feels so sudden and so urgent.

OAB comes in two forms. OAB wet is OAB with urge incontinence, you feel the urgency and also leak urine when you cannot reach the toilet in time, from a few drops to a full accident. OAB dry is urgency, frequency and nocturia without leaking, you make it to the toilet but your life still revolves around finding one. Both forms hit quality of life hard.

It is worth telling OAB apart from stress urinary incontinence, where urine escapes with a cough, sneeze, laugh or lifting because the pelvic floor support of the urethra is weak. OAB leaks come after an urge, not with physical effort. Many women have mixed urinary incontinence, with features of both, particularly after childbirth and menopause.

Causes and contributors include age (the most consistent risk factor), the oestrogen drop after menopause (part of the genitourinary syndrome of menopause), neurological conditions (stroke, Parkinson's, multiple sclerosis, spinal problems, and diabetes with nerve damage), bladder problems (stones, infection, rarely cancer), pelvic organ prolapse, recurrent urinary tract infections, constipation, some medicines (especially water pills), and too much caffeine or alcohol. In many women no single cause is found, this is called idiopathic OAB, and it is still very treatable.

A bladder diary (also called a frequency-volume chart) is the single most useful first step. Over 3-7 typical days you note every drink (what, when, how much), every pee (time and volume, measured in a marked cup or mug), every leak (time, how much, what you were doing), and every strong urge. You can keep it on paper or in a notes app on your phone.

The diary turns vague complaints into hard facts. It shows whether you are drinking too much, how often you go by day and by night, how big each pee is (small volumes point to OAB), and what triggers your leaks. For example, large pre-bed cups of chai often explain night-time trips, and small, frequent voids with sudden urges fit an OAB pattern. Large night-time urine volumes point instead to nocturnal polyuria, which needs different assessment.

Alongside the diary, your doctor will take a detailed history (symptoms, triggers, fluids, medicines, deliveries, menopause status, bowel habits), examine you (including a pelvic exam to check for prolapse, tissue thinning or infection), and send a urine routine and culture to rule out infection. A quick post-void ultrasound checks how much urine is left after you pee, as poor emptying can mimic OAB. Urodynamic studies (a detailed pressure test of bladder filling and emptying, roughly Rs 3,500-12,000 privately, far less in government hospitals) are not routine, they are reserved for unclear or stubborn cases, or before advanced treatment.

Lifestyle and behaviour changes are the foundation of OAB care and, on their own, help a great many women avoid medicines altogether.

Get fluids right, not low. Aim for a moderate 1.5-2 litres a day (a little more in heat or if you are very active). Drinking far too much floods the bladder, but drinking far too little to avoid leaks concentrates your urine, which irritates the bladder and makes urgency worse. Spread your fluids through the day and ease off in the 3-4 hours before bed to cut night-time trips.

Trim bladder irritants. Tea, coffee, cola, alcohol, fizzy drinks, artificial sweeteners, very spicy food, citrus and tomato-heavy dishes commonly stir up the bladder. Cut back on the ones you have most for 2-3 weeks while tracking your diary to see what actually helps you.

Treat constipation. A full, hard bowel presses on the bladder and shares its nerves, so chronic constipation worsens OAB. Aim for 25-30 g fibre a day, plenty of water, isabgol if needed, a regular toilet routine and a footstool for a better squatting position. This matters even more if you take anticholinergic medicines, which can themselves cause constipation, and is a known issue around menopause too, as covered in menopause and constipation.

Retrain your bladder. Bladder retraining gradually stretches the gap between pees. Start at your current interval (say 1-1.5 hours from your diary) and add 15-30 minutes each week, using urge-control tricks, a firm pelvic floor squeeze, slow breathing and distraction, to ride out the urge instead of dashing off. Over 6-12 weeks most women reach comfortable 3-4 hour gaps. Pair this with Kegel and pelvic floor exercises: a good squeeze both supports the urethra and reflexively calms the bladder. A women's-health physiotherapist can guide the whole programme, and the same skills help with pelvic floor recovery after childbirth.

Anticholinergics (also called antimuscarinics) are the established first-line tablets for OAB. They block muscarinic receptors on the bladder muscle, calming involuntary contractions and improving how much the bladder can comfortably hold. Several options exist with broadly similar effectiveness but different side-effect profiles.

Commonly used agents in India include tolterodine (2 mg twice daily, or 4 mg once daily extended-release), solifenacin (5-10 mg once daily, well targeted to the bladder), and the older oxybutynin (more side effects). Darifenacin, trospium and fesoterodine are also available. Generic costs are modest, roughly Rs 100-800 a month depending on the drug, with branded versions Rs 400-1,500 a month. Most women notice a clear improvement in urgency, frequency and leaks within 2-4 weeks, though full benefit can take a couple of months at the target dose.

The main side effects are dry mouth (most common), constipation, blurred vision, dry eyes and, occasionally, urinary retention. In older women there is growing concern about anticholinergics and cognitive effects, including a possible link with dementia over long-term use, so a different drug (mirabegron, below) is often preferred past about 65. They are avoided in narrow-angle glaucoma, significant gut obstruction and urinary retention. If one anticholinergic does not suit you, switching to another is reasonable, and combining the tablet with the behaviour changes above gives the best results.

Mirabegron (25-50 mg once daily) works in a completely different way to anticholinergics. It switches on beta-3 receptors on the bladder muscle, helping it relax and store more urine. Its big advantage is tolerability, no dry mouth, no constipation and none of the cognitive worries, which makes it a popular first choice in older women or anyone who cannot tolerate anticholinergics.

Its effectiveness is broadly similar to the anticholinergics for urgency, frequency, leaks and quality of life. Some women do better on one class than the other, and combining mirabegron with a low-dose anticholinergic is increasingly used when neither alone is enough. The trade-off is cost: mirabegron runs about Rs 400-1,200 a month for the 25 mg dose and Rs 800-2,000 for 50 mg, noticeably more than generic anticholinergics, which matters for many families.

Its main caution is blood pressure, it can nudge BP up, so it is avoided in uncontrolled hypertension, and your BP should be checked before and during treatment; in well-controlled hypertension it can be used with monitoring. Other possible effects are occasional fast heartbeat, headache and urinary infection. Improvement usually appears over 4-8 weeks. As with all OAB medicines, results are best when you also address fluids, irritants, constipation and bladder retraining rather than relying on the tablet alone.

When behaviour changes plus first- and second-line tablets have not done enough, effective advanced treatments are available, and they are well worth considering rather than giving up.

Bladder Botox (intradetrusor botulinum toxin) is the most established. Around 100 units (occasionally 200 for severe cases) is injected into several spots on the bladder wall through a cystoscope, under local or sometimes general anaesthetic. It is a 15-30 minute day-case procedure. Most responders see a big drop in urgency and leaks within 2-4 weeks, lasting on average 6-9 months, after which the injection is repeated. The main risks are urinary infection (common, treated with antibiotics) and a temporary rise in leftover urine, which occasionally needs a short period of clean intermittent self-catheterisation, so counselling about this beforehand matters. It costs roughly Rs 20,000-60,000 per session privately and far less in government hospitals, and is offered at major urogynaecology and urology centres such as AIIMS, Apollo, Fortis, Manipal, KEM Mumbai and CMC Vellore.

Sacral neuromodulation (SNM) is the most advanced surgical option for stubborn OAB. A small implantable device (such as InterStim or Axonics) gently stimulates the sacral nerves that control the bladder. It is done in stages, a test phase with an external stimulator first, then a permanent implant only if the test works well. Continence improves substantially in roughly 60-80% of responders, with benefit lasting years (the battery is replaced every 5-10 years). It is available at a limited number of Indian centres and costs around Rs 5-10 lakh including the device, so it is reserved for severe cases that have not responded to everything else. Posterior tibial nerve stimulation (PTNS), weekly 30-minute sessions stimulating a nerve at the ankle for 12 weeks, is a lower-cost, lower-risk middle option with more modest evidence.

Menopause changes the bladder and urethra directly, so it deserves its own attention. As oestrogen falls, the tissues of the vagina and urethra thin and the protective lactobacilli dwindle, a cluster of changes called the genitourinary syndrome of menopause. This drives urgency, frequency and night-time peeing, and makes recurrent urinary infections more likely, which in turn flare OAB symptoms. You can read more in our guide to vaginal dryness and atrophy after menopause.

Low-dose vaginal oestrogen is one of the most useful and most under-used treatments here. Estriol or estradiol creams, tablets or rings are applied locally (often nightly for two weeks, then twice a week). Because almost none is absorbed into the bloodstream, the breast-cancer and clot concerns of systemic hormone replacement therapy largely do not apply. Indian Menopause Society guidance supports vaginal oestrogen as first-line for genitourinary syndrome and as a helpful add-on for OAB and recurrent infection, with clear improvement usually over 6-12 weeks. (Systemic menopausal hormone therapy is a separate decision, weighed up in our hormone therapy explainer.)

For older women, combination therapy works well, vaginal oestrogen plus an OAB medicine (often mirabegron, given its kinder side-effect profile) plus behaviour changes and pelvic floor work. Two extra issues matter in this age group: falls (rushing to the toilet with urgency is a real fall risk) and medication load (the more anticholinergic medicines someone takes for other conditions, the higher the cumulative burden). Night-time peeing also tangles with poor sleep, sometimes linked to sleep apnoea in postmenopausal women, which is worth checking if you snore and sleep badly.

Mixed urinary incontinence combines leaking on effort (the stress type) with urge leaks, and it is common in women with several risk factors: childbirth, age, menopause and prolapse. Treatment tackles both parts, usually starting with whichever bothers you most. If the stress component dominates, the focus is pelvic floor exercises and, for severe cases, sling surgery; if the urge component dominates, behaviour changes and OAB medicines come first.

Several conditions overlap with OAB. Pelvic organ prolapse can cause urinary symptoms and may need its own treatment. Recurrent infections both trigger and are worsened by OAB. Painful bladder syndrome (interstitial cystitis) causes bladder pain on top of OAB-like symptoms and needs a different approach, and persistent pelvic pain deserves its own work-up, as covered in our guide to chronic pelvic pain. Diabetes feeds OAB through nerve effects and high urine sugar, so good glucose control helps.

Two more contributors are easy to miss. Constipation both worsens OAB and complicates medicine choice, so treat it actively. And the mind-bladder link is real, Depression and Anxiety in Indian Women: Symptoms and Help can amplify urgency through the nervous system, while OAB itself can fuel social anxiety about toilet access. Treating both together often helps. Complex cases do best with a team: urogynaecologist or urologist, women's-health physiotherapist, your gynaecologist or GP, and mental-health support where needed.

Early OAB care can begin with your GP or gynaecologist, a bladder diary, lifestyle changes, vaginal oestrogen after menopause, and a first-line medicine. See a doctor sooner rather than later if symptoms are affecting your work, sleep or social life, you are too anxious about toilets to go out, or simple measures are not helping.

Some symptoms need prompt medical attention rather than watchful waiting. Get checked without delay if you notice blood in your urine, pain or burning when you pee with fever or back pain (a possible kidney infection), sudden inability to pass urine, or new urinary symptoms alongside weakness, numbness or trouble walking. These point away from simple OAB and need urgent assessment.

Ask for referral to a urogynaecologist or urologist if the diagnosis is unclear, first-line measures have not worked, there are complicating factors (significant prolapse, poor bladder emptying, severe leaks), or you are considering advanced treatment such as Botox or neuromodulation. At that visit, expect a detailed history, a pelvic exam, urine tests, a post-void ultrasound and, in selected cases, urodynamic studies. The Indian Continence Society and urogynaecology units at teaching hospitals maintain directories of trained specialists, and telehealth platforms can handle initial and follow-up consults, though examinations and procedures need an in-person visit. Most women see real improvement within 2-4 months of starting structured treatment.

Early-stage OAB care is broadly affordable, with costs rising only for advanced treatments. As a rough private-sector guide: GP consult Rs 300-1,000, gynaecology Rs 500-2,500, urogynaecology or urology Rs 800-3,000. Urine routine and culture Rs 300-1,200, post-void ultrasound Rs 500-2,000, urodynamic studies Rs 3,500-12,000 (much less in government hospitals).

Medicines are generally inexpensive at the start: generic anticholinergics roughly Rs 100-800 a month, mirabegron Rs 400-2,000 a month, vaginal oestrogen cream Rs 300-1,200 a tube lasting 2-3 months, and pelvic floor physiotherapy Rs 500-2,500 a session.

Advanced options cost more: bladder Botox Rs 20,000-60,000 per session (repeated every 6-9 months), sacral neuromodulation Rs 5-10 lakh including the device, and PTNS roughly Rs 30,000-80,000 for a 12-session course. OAB care is offered at AIIMS, Apollo, Fortis, Manipal, KEM Mumbai, CMC Vellore, JIPMER and Indian Continence Society member institutions. Government schemes (Ayushman Bharat, ESI, CGHS and state schemes) cover most costs for eligible patients, while private insurance cover for OAB varies by policy, so check your terms before planning a procedure.

• NICE Guideline NG123: Urinary incontinence and pelvic organ prolapse in women
• NHS: Urinary incontinence
• American Urological Association (AUA/SUFU): Diagnosis and Treatment of Non-Neurogenic Overactive Bladder-guideline)
• ACOG: Urinary Incontinence in Women
• Office on Women's Health (US): Urinary incontinence